review article | Q7318358 |
scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1046549913 |
P356 | DOI | 10.1023/A:1026647417465 |
P698 | PubMed publication ID | 10389675 |
P5875 | ResearchGate publication ID | 12908895 |
P2093 | author name string | Koch KL | |
P2860 | cites work | The treatment of idiopathic and diabetic gastroparesis with acute intravenous and chronic oral erythromycin. | Q30467463 |
The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. | Q30470587 | ||
Asymptomatic gastric retention in diabetics (gastroparesis diabeticorum) | Q77052405 | ||
Diabetic gastric atony: a clinical study | Q79114436 | ||
Hyperglycaemia stimulates pyloric motility in normal subjects | Q34393861 | ||
Electrical arrhythmias in the human stomach | Q34495541 | ||
Intestinal manometry?Technical advances, clinical limitations | Q36730183 | ||
Disordered gastric motor function in diabetes mellitus. Recent insights into prevalence, pathophysiology, clinical relevance, and treatment | Q37312300 | ||
Definition and investigation of dyspepsia. Consensus of an international ad hoc working party | Q38667544 | ||
Metoclopramide: pharmacology and clinical application | Q40144011 | ||
Disorders of gastrointestinal motility associated with diabetes mellitus | Q40206633 | ||
Domperidone. A review of its pharmacological activity, pharmacokinetics and therapeutic efficacy in the symptomatic treatment of chronic dyspepsia and as an antiemetic | Q40248870 | ||
Cisapride. An updated review of its pharmacology and therapeutic efficacy as a prokinetic agent in gastrointestinal motility disorders | Q40387175 | ||
Gastroduodenal motility and dysmotility: an update on techniques available for evaluation. | Q40539651 | ||
Diabetic gastroparesis: a review | Q41087836 | ||
Ultrasonography of the human stomach. | Q41193652 | ||
Dyspepsia of unknown origin: pathophysiology, diagnosis, and treatment | Q41687682 | ||
Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride | Q43433150 | ||
Human gastric pacesetter potential. Site of origin, spread, and response to gastric transection and proximal gastric vagotomy | Q44307631 | ||
A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis | Q44860382 | ||
Suppression of pregnancy-induced nausea and vomiting with sensory afferent stimulation. | Q46638819 | ||
Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans | Q49123709 | ||
There are no morphologic abnormalities of the gastric wall or abdominal vagus in patients with diabetic gastroparesis. | Q50896889 | ||
Lower postprandial gastric volume response in diabetic patients with vagal neuropathy. | Q51576595 | ||
Wide gastric antrum and low vagal tone in patients with diabetes mellitus type 1 compared to patients with functional dyspepsia and healthy individuals. | Q51584025 | ||
Gastric myoelectrical activity in patients with type I diabetes mellitus and autonomic neuropathy. | Q51592979 | ||
Reversal of gastric electrical dysrhythmias by cisapride in children with functional dyspepsia. Report of three cases. | Q51605004 | ||
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction. | Q51622063 | ||
Pyloric dysfunction in diabetics with recurrent nausea and vomiting. | Q51633620 | ||
Gastric motor abnormalities in diabetic and postvagotomy gastroparesis: effect of metoclopramide and bethanechol. | Q51659975 | ||
Effect of stimulation of the P6 antiemetic point on postoperative nausea and vomiting. | Q51746657 | ||
Measurement of gastric emptying rate of solids by means of a carbon-labeled octanoic acid breath test. | Q52395160 | ||
Effect of barium meals on gastric electromechanical activity in man. A fluoroscopic-electrogastrographic study. | Q52585611 | ||
Gastrointestinal involvement in insulin-requiring diabetes mellitus | Q68688912 | ||
Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies | Q68741659 | ||
Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus | Q68989565 | ||
Electrogastrography: current issues in validation and methodology | Q69002620 | ||
Gastric and oesophageal emptying in patients with type 2 (non-insulin-dependent) diabetes mellitus | Q69665480 | ||
Gastrointestinal symptoms in diabetic patients: lack of association with neuropathy | Q69672864 | ||
Gastric emptying in patients with insulin-requiring diabetes mellitus | Q69710503 | ||
Gastric emptying and gastric myoelectrical activity in patients with diabetic gastroparesis: effect of long-term domperidone treatment | Q69714442 | ||
Acute and chronic effects of domperidone on gastric emptying in diabetic autonomic neuropathy | Q70044293 | ||
Non-invasive stimulation of the P6 (Neiguan) antiemetic acupuncture point in cancer chemotherapy | Q70147307 | ||
Hyperglycaemia slows gastric emptying in type 1 (insulin-dependent) diabetes mellitus | Q70245065 | ||
The enteric nervous system | Q70995216 | ||
Measurement of proximal and distal gastric motility with magnetic resonance imaging | Q71404664 | ||
Functional disorders of the stomach | Q71748029 | ||
Gastric neuropathy in diabetes mellitus: clinical and radiologic observations | Q72027624 | ||
Mediation of hyperglycemia-evoked gastric slow-wave dysrhythmias by endogenous prostaglandins | Q72590080 | ||
Effect of autonomic nervous system dysfunction on the circadian pattern of myocardial ischemia in diabetes mellitus | Q72726510 | ||
Electrogastrography in patients with gastroparesis and effect of long-term cisapride | Q72863360 | ||
Disordered eating behavior and microvascular complications in young women with insulin-dependent diabetes mellitus | Q73445274 | ||
Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus | Q73475858 | ||
P433 | issue | 6 | |
P921 | main subject | pathophysiology | Q1135939 |
P304 | page(s) | 1061-1075 | |
P577 | publication date | 1999-06-01 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Diabetic gastropathy: gastric neuromuscular dysfunction in diabetes mellitus: a review of symptoms, pathophysiology, and treatment | |
P478 | volume | 44 |
Q37086144 | A stable isotope breath test with a standard meal for abnormal gastric emptying of solids in the clinic and in research |
Q35587520 | Alterations of colonic contractility in long-term diabetic rat model |
Q28239882 | Analysis of the electrogastrogram using discrete wavelet transform and statistical methods to detect gastric dysrhythmia |
Q46103462 | Association between metabolic syndrome and prevalence of gastroesophageal reflux disease in a health screening facility in Japan |
Q36057076 | Association between psychological distress and gastrointestinal symptoms in diabetes mellitus |
Q33564976 | Atrial natriuretic peptide signal pathway upregulated in stomach of streptozotocin-induced diabetic mice |
Q46327851 | Blood and plasma pharmacokinetics of ciclosporin in diabetic kidney transplant recipients |
Q34973979 | Celiac plexus block in a patient with upper abdominal pain caused by diabetic gastroparesis |
Q33787539 | Cellular pathogenesis of diabetic gastroenteropathy. |
Q43717014 | Changes in serotonin levels and 5-HT receptor activity in duodenum of streptozotocin-diabetic rats |
Q37501020 | Characterization of smooth muscle, enteric nerve, interstitial cells of Cajal, and fibroblast-like cells in the gastric musculature of patients with diabetes mellitus |
Q80942731 | Chronic gastric electrical stimulation for gastroparesis reduces the use of prokinetic and/or antiemetic medications and the need for hospitalizations |
Q35035103 | Chronic metoclopramide therapy for diabetic gastroparesis |
Q35962949 | Clinical-histological associations in gastroparesis: results from the Gastroparesis Clinical Research Consortium |
Q35162310 | Current concepts in diabetic gastroparesis |
Q31094892 | Deficiency of KIT-positive cells in the colon of patients with diabetes mellitus |
Q44468853 | Delta9-tetrahydrocannabinol selectively acts on CB1 receptors in specific regions of dorsal vagal complex to inhibit emesis in ferrets |
Q46989321 | Determination of gastric emptying in nonobese diabetic mice |
Q28578225 | Diabetes induces sex-dependent changes in neuronal nitric oxide synthase dimerization and function in the rat gastric antrum |
Q63987568 | Diabetic Gastroparesis: Principles and Current Trends in Management |
Q35054446 | Diabetic gastroparesis: Therapeutic options. |
Q34378282 | Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years: Figure 1 |
Q35068007 | Diabetic gastropathy and prokinetics |
Q35176981 | Diagnosis and treatment of chronic gastroparesis and chronic intestinal pseudo-obstruction. |
Q35178779 | Diagnosis and treatment of neuromuscular disorders of the stomach |
Q43572615 | Differential gene expression in the small intestines of wildtype and W/W(V) mice |
Q48033096 | Distribution of interstitial cells of Cajal and nitrergic neurons in normal and diabetic human appendix |
Q46701598 | Disturbed gastrointestinal motility and decreased interstitial cells of Cajal in diabetic db/db mice |
Q82647878 | Does Grading the Severity of Gastroparesis Based on Scintigraphic Gastric Emptying Predict the Treatment Outcome of Patients with Gastroparesis? |
Q43967110 | Domperidone is more effective than cisapride in children with diabetic gastroparesis. |
Q36616827 | Effect of Gongronema latifolium on gastric emptying in healthy dogs |
Q44579051 | Effect of mosapride on glycemic control and gastric emptying in type 2 diabetes mellitus patients with gastropathy |
Q50697799 | Effect of vitamin E on diabetes-induced changes in small intestine and plasma antioxidant capacity in rat. |
Q37898419 | Effects of environment and lifestyle on gastroesophageal reflux disease |
Q48832942 | Electroacupuncture restores impaired gastric accommodation in vagotomized dogs |
Q38076716 | Electrogastrography: methodology, validation and applications |
Q37598598 | Factors contributing to hospitalization for gastroparesis exacerbations |
Q84693566 | Gastric Electrical Stimulation and the “Eye of the Beholder” |
Q44325721 | Gastric emptying in animal models of human diabetes: correlation to blood glucose level and gut neuroendocrine peptide content |
Q34579697 | Gastric emptying in diabetes: clinical significance and treatment. |
Q37724669 | Gastric nNOS reduction accompanied by natriuretic peptides signaling pathway upregulation in diabetic mice |
Q43682803 | Gastroesophageal reflux disease related to diabetes: Analysis of 241 cases with type 2 diabetes mellitus. |
Q45150416 | Gastrointestinal alterations in diabetes mellitus: oxidative stress and blood flow in the superior mesenteric artery--experimental study |
Q44325724 | Gastrointestinal transit in an animal model of human diabetes type 2: relationship to gut neuroendocrine peptide contents |
Q43740714 | Gastrointestinal transit in nonobese diabetic mouse: an animal model of human diabetes type 1. |
Q44895114 | Gastroparesis following kidney/pancreas transplant |
Q37186013 | Gastroparesis in pregnancy: case report and literature review |
Q53830434 | Glucose sensor-augmented continuous subcutaneous insulin infusion in patients with diabetic gastroparesis: An open-label pilot prospective study. |
Q37357244 | Gongronema latifolium delays gastric emptying of semi-solid meals in diabetic dogs |
Q38457192 | High-fat diet ingestion correlates with neuropathy in the duodenum myenteric plexus of obese mice with symptoms of type 2 diabetes |
Q38350183 | Histologic changes in diabetic gastroparesis |
Q43900841 | Hyperglycemia impairs antro-pyloric coordination and delays gastric emptying in conscious rats |
Q52552285 | Immunomagnetic enrichment of interstitial cells of Cajal |
Q40401845 | Impact of myenteric plexus alterations on diabetes related gastrointestinal dysmotility |
Q43521785 | Impairment of the proximal to distal tonic gradient in the human diabetic stomach |
Q36312575 | Insulin reduces excitation in gastric-related neurons of the dorsal motor nucleus of the vagus |
Q35126913 | Insulin restores neuronal nitric oxide synthase expression and function that is lost in diabetic gastropathy. |
Q43618809 | Intrapyloric injection of botulinum toxin a for the treatment of persistent gastroparesis following successful pancreas transplantation |
Q46959356 | Localization of protein kinase C theta immunoreactivity to interstitial cells of Cajal in guinea-pig gastrointestinal tract |
Q48382124 | Morphological substrate of the catecholaminergic input of the vasopressin neuronal system in humans |
Q87375018 | Mosapride citrate increases postprandial glucagon-like peptide-1, insulin, and gene expression of sweet taste receptors |
Q44585597 | Multimodal assessment of optokinetic visual stimulation response in migraine with aura. |
Q38276835 | Nausea: current knowledge of mechanisms, measurement and clinical impact. |
Q24297427 | Novel human and mouse genes encoding an acid phosphatase family member and its downregulation in W/W(V) mouse jejunum |
Q28217275 | Peptide YY in gastrointestinal disorders |
Q34605626 | Physiology and pathophysiology of the interstitial cells of Cajal: from bench to bedside. IV. Genetic and animal models of GI motility disorders caused by loss of interstitial cells of Cajal |
Q43593222 | Postprandial blood glucose latency after oatmeal is a valid screening test for diabetic gastropathy in type 1 diabetes, but not in type 2 diabetes |
Q51067220 | Psychological distress is linked to gastrointestinal symptoms in diabetes mellitus. |
Q28301264 | Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system |
Q36206689 | Sickness and satiety: physiological mechanisms underlying perceptions of nausea and stomach fullness |
Q28362551 | Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice |
Q46520100 | Tetrahydrobiopterin deficiency induces gastroparesis in newborn mice. |
Q37250932 | The incidence, prevalence, and outcomes of patients with gastroparesis in Olmsted County, Minnesota, from 1996 to 2006. |
Q50097195 | Triggers of motion sickness in migraine sufferers |
Q33867705 | Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus |
Q34637433 | Use of electrogastrography in children |
Q48391867 | Visually induced nausea causes characteristic changes in cerebral, autonomic and endocrine function in humans. |
Q51679551 | Vomiting and gastric electrical dysrhythmia in dogs. |